Dr. Edward Morgan
Dr. Eddie Morgan received a B.Sc. (Honours) in Pharmacology and a Ph.D. in Pharmacology from the University of Glasgow. As a Postdoctoral Fellow with Minor J Coon at the University of Michigan from 1979-82, Dr. Morgan teamed with Dr. Dennis Koop to identify, purify and characterize a novel ethanol-induced P450 protein, CYP2E1. He then moved to the Karolinska Institute as a Visiting Scientist with Prof. Jan-Åke Gustafsson. They were the first to demonstrate that expression of sex-specific forms of cytochrome P450 in rodents are regulated by the pulsatile pattern of Growth Hormone secretion. He joined the faculty at Emory University in 1986, where he is now Professor of Pharmacology and Chemical Biology. Dr. Morgan’s research interests at Emory have focused on the regulation of cytochrome P450 enzymes under conditions of inflammation and infection, and he provided the first evidence that such regulation occurs via suppression of gene transcription. His current research interests are in post-translational regulation of P450s by nitric oxide, and on developing methods to annotate the human xenobiotic metabolome.
Dr. Morgan is a member of the American Society of Pharmacology and Experimental Therapeutics (ASPET) and the International Society for the Study of Xenobiotics (ISSX). He is currently President of ASPET. He also served ASPET as Secretary/Treasurer, Chair of the Division of Drug Metabolism and Disposition, and on the Board of Publications Trustees. He was the Editor in Chief of Drug Metabolism and Disposition from 2012 to 2017 and is a former Associate Editor of Molecular Pharmacology.
Dr. Morgan has long-standing commitment to graduate student training, and to increasing diversity and inclusion in the STEM disciplines. He is currently a principal investigator of Emory’s NIH-funded Initiative for Maximizing Student Development (IMSD) program, and President and a founding member of the Atlanta Society of Mentors.
